Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 111   

Articles published

SHP 5,350.00 +40.00 (0.75%)
price chart
Are SkyePharma PLC And Spire Healthcare Group PLC Better Buys Than Shire ...
And, even though both companies have bottom lines that are not particularly impressive, they continue to have upbeat forecasts for the next couple of years.
Shire Plc, Cincinnati Children's Establish Rare Disease Research Collaboration
According to both the companies, the goal of the collaboration is to discover and develop novel therapies to treat rare diseases with high unmet medical need combining Shire's development and commercialization capabilities with Cincinnati Children's ...
Cincinnati Children's inks deal with Shire to develop drugs  Cincinnati Business Courier
Shire Establishes Research Collaboration With Cincinnati Hospital  London South East
3 Tips For Your 2015 ISA: National Grid plc, Reckitt Benckiser Group Plc ...
National Grid (LSE: NG), Reckitt Benckiser (LSE: RB) and Shire (LSE: SHP) are three shares that you certainly ought to consider for your 2015 ISA.
3 Attractive Growth Shares For My 2015 ISA Watchlist: easyjet Plc, ARM ...
As the markets flirt with new highs, it is perhaps a reasonable assumption that there could well be a correction just around the corner.
Why GlaxoSmithKline plc And Shire plc Are Dividend And Growth Buys
GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) would be my pick of the pharmaceutical companies to invest in at the moment.
Is Bioquell plc The Perfect Partner For Shire PLC And BTG plc In Your Portfolio?
Shares in decontamination specialist, Bioquell (LSE: BQE), have surged by as much as 36% today after the company announced the sale of its specialist testing subsidiary, TRaC, for �44.5m in cash.
Why I'm Selling GlaxoSmithKline plc And Buying Shire PLC
Finding a company that has the perfect blend of both growth and income is a difficult game to play. However, it looks as if Shire (LSE: SHP) could be the perfect pick. Up until now, my pharmaceutical sector favourite has been GlaxoSmithKline (LSE: GSK ...
Why ARM Holdings plc, Inmarsat Plc, Reckitt Benckiser Group Plc, Shire PLC ...
Despite a fall at the start of the month, the FTSE 100 has been picking up again over the past week, driven further towards that elusive 7,000 level by its high flyers.
Keep An Eye On Smith & Nephew plc & Shire plc Now!
Smith & Nephew (LSE: SN) has lost 7.5% of value in less than a day after US rival Stryker announced a $2bn stock buyback programme.
Here's Why The Market Hates GlaxoSmithKline plc, But Loves Shire plc
I am attracted to Shire because it has been much more aggressive than its rivals in its corporate strategy, as its latest purchase of NPS Pharmaceuticals signals. Shire is exploiting its balance sheet at a time other pharma players have been more ...